PB RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2003) 27: 17-19. doi: 10.1192/pb.27.1.17
© 2003 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Acosta-Armas, A. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Acosta-Armas, A. J.
Psychiatric Bulletin (2003) 27: 17-19
© 2003 The Royal College of Psychiatrists

Problems encountered when testing for LSD in a regional medium secure unit

A. J. Acosta-Armas, Specialist Registrar in Forensic Psychiatry

Devon Partnership NHS Trust, Langdon Hospital, Exeter Road, Dawlish, Devon EX7 0NR

AIMS AND METHOD

Between 1998 and 2000, a surprisingly high number of positive results was noticed in our regional medium secure unit when testing for D-lysergic acid diethylamide (LSD). This led to an investigation of possible factors involved. It was felt that the testing protocol, particularly the use of a single, non-isotopic homogeneous immunoassay without routine further confirmatory testing, was largely to blame for what seemed to be a high incidence of false positives. On two different occasions, samples from each patient were sent, on the same day, to two different laboratories. At the first laboratory, only one test method was used and at the second one test plus two confirmatory tests were carried out.

RESULTS

Out of a total of 23 patients tested on two separate occasions, the first laboratory gave three positive results the first time and three positive results the second, while the second laboratory gave only one positive result on the second occasion that samples were sent and none on the first. This reinforces the belief that, without adequate confirmatory analysis, many psychiatric and non-psychiatric prescribed drugs can give false positives.

CLINICAL IMPLICATIONS

Positive LSD results should be confirmed by at least one, preferably chromatographic, alternative method. A protocol for testing and reporting LSD in psychiatric patients should be considered in order to minimise the risk of obtaining false-positive results which have negative clinical, legal and psychological repercussions.




This article has been cited by other articles:


Home page
Psychiatr. Bull.Home page
S. E. Adhami
False-positive drug tests
Psychiatr. Bull., July 1, 2005; 29(7): 276 - 276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2003 The Royal College of Psychiatrists.